Consequently, there was a significant reduction in the percentage of CD2+MHC-II+CCR2+ myeloid precursors interacting with CD200+ fibroblasts in individuals with PsA compared to in those with psoriasis (Fig. 5g). This evidence concerns the gene CD200 and psoriasis.